mercaptamine   Click here for help

GtoPdb Ligand ID: 7440

Synonyms: CI-9148 | Cystagon® | Cystaran® | cysteamine hydrochloride | L-1573
Approved drug PDB Ligand
mercaptamine is an approved drug (FDA (1994), EMA (1997))
Compound class: Synthetic organic
Comment: Mercaptamine is the simplest stable aminothiol, and a degradation product of the amino acid cysteine.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 1
Topological polar surface area 64.82
Molecular weight 77.03
XLogP 0.11
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCS
Isomeric SMILES NCCS
InChI InChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2
InChI Key UFULAYFCSOUIOV-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
The bitartrate and hydrochloride salt forms are indicated for the treatment of neuropathic cystinosis, and to treat radiation sickness. Link to ClinicalTrials.gov to view currently registered trials assessing efficacy of this drug for additional indications.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
The inherited lysosomal storage disease, cystinosis is characterized by the abnormal accumulation of the amino acid cystine and arises through inheritance of mutations in the lysosomal cystine transporter gene (CTNS, O60931). Intracellular cystine accumulation and crystallization causes widespread tissue damage. The free thiol group of cysteamine cleaves the disulphide bond in cystine, thereby allowing excretion of the cystine byproducts.
External links Click here for help